BioPen systems are unique and powerful microfluidic devices for targeted molecule delivery that make it possible to deliver up to 4 different compounds or concentration levels with one single disposable tip. It allows control of the chemical environment around single intact cells in tissue or cell cultures. BioPen allows you to directly target individual cells without risk of contamination and low compound consumption with full control of positioning and timing of the system. These systems are also compatible with most of the micromanipulation devices and microscopes.
Benefits
Target single cells
Directly target individual cells or a small number of cells adherent to compounds, like drugs or antibodies, without diffusion outside the region of interest.
Rapid delivery
Rapid delivery up to 4 different compounds to just a single cell or part of a cell with sub-second exchange time.
Low compound consumption
4 integrated wells with less than 35 microliters overcome the usual dead volume problem of external tubing. This significantly reduces the need for expensive reagents.
Combination with other probing devices
The BioPen is compatible with many probing devices, such as optical fibers or electrodes and patch-clamp pipettes. The pipette tip can fit into any micro-manipulation environment which means easy combination with the other probing devices.
No glass or tip breakage
The pipette tips are made with a unique biocompatible material that is flexible and doesn’t break due to impact on a hard surface, unlike glass pipettes.
No risk of contamination
The hydrodynamically confined flow principle-based pipette allows contamination-free confinement of one miscible liquid inside another.
To learn more about BioPen microfluidic targeted molecule delivery, callNexus Scientific, authorized distributors of Fluicell® BioPen systems in the US at 857-217-0936. Located in Boston, MA, Nexus Scientific is a Life Science Equipment Supplier that offers International Trade, US Distribution of Equipment as well as pre-sale to post-sale support to Academic Research groups, Hospitals, and Biotech and Pharmaceutical companies.